Global Egg-Based Flu Vaccines Supply, Demand and Key Producers, 2023-2029

Global Egg-Based Flu Vaccines Supply, Demand and Key Producers, 2023-2029

The global Egg-Based Flu Vaccines market size is expected to reach $ 10170 million by 2029, rising at a market growth of 4.8% CAGR during the forecast period (2023-2029).

A significant driver in the Influenza Vaccine market is the growing awareness of the importance of vaccination in preventing seasonal and pandemic influenza outbreaks. As healthcare organizations and governments worldwide promote vaccination as a crucial public health measure, there is an increasing demand for influenza vaccines. Additionally, advances in vaccine research and development, including the production of more effective and broader-spectrum vaccines, are driving market growth. One of the key challenges in this market is the need for frequent vaccine updates to match evolving influenza strains. The virus undergoes genetic changes, requiring annual adjustments to vaccine formulations. This presents logistical challenges for manufacturers in terms of timely production and distribution. Vaccine hesitancy and misinformation also pose challenges by impacting vaccination rates and public perception. Lastly, ensuring equitable access to vaccines, especially in low-income and underserved populations, remains a persistent challenge in the fight against influenza.

The most common way that flu vaccines are made is using an egg-based manufacturing process. that has been used for more than 70 years. Egg-based vaccine manufacturing is used to make both inactivated (killed) vaccine (usually called the “flu shot”) and live attenuated (weakened virus) vaccine (usually called the “nasal spray flu vaccine”).

This report studies the global Egg-Based Flu Vaccines production, demand, key manufacturers, and key regions.

This report is a detailed and comprehensive analysis of the world market for Egg-Based Flu Vaccines, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Egg-Based Flu Vaccines that contribute to its increasing demand across many markets.

Highlights and key features of the study

Global Egg-Based Flu Vaccines total production and demand, 2018-2029, (K Units)

Global Egg-Based Flu Vaccines total production value, 2018-2029, (USD Million)

Global Egg-Based Flu Vaccines production by region & country, production, value, CAGR, 2018-2029, (USD Million) & (K Units)

Global Egg-Based Flu Vaccines consumption by region & country, CAGR, 2018-2029 & (K Units)

U.S. VS China: Egg-Based Flu Vaccines domestic production, consumption, key domestic manufacturers and share

Global Egg-Based Flu Vaccines production by manufacturer, production, price, value and market share 2018-2023, (USD Million) & (K Units)

Global Egg-Based Flu Vaccines production by Type, production, value, CAGR, 2018-2029, (USD Million) & (K Units)

Global Egg-Based Flu Vaccines production by Application production, value, CAGR, 2018-2029, (USD Million) & (K Units).

This reports profiles key players in the global Egg-Based Flu Vaccines market based on the following parameters – company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Sanofi, CSL, GSK, Viatris, AstraZeneca, Hualan Bio, Changchun Institute of Biological, Sinovac and BCHT, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Egg-Based Flu Vaccines market.

Detailed Segmentation:

Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.

Global Egg-Based Flu Vaccines Market, By Region:
United States
China
Europe
Japan
South Korea
ASEAN
India
Rest of World

Global Egg-Based Flu Vaccines Market, Segmentation by Type
Trivalent Influenza Vaccine
Quadrivalent Influenza Vaccine

Global Egg-Based Flu Vaccines Market, Segmentation by Application
6 Months to 3 Years
> 3 Years

Companies Profiled:
Sanofi
CSL
GSK
Viatris
AstraZeneca
Hualan Bio
Changchun Institute of Biological
Sinovac
BCHT
Jiangsu GDK
KM Biologics

Key Questions Answered

1. How big is the global Egg-Based Flu Vaccines market?

2. What is the demand of the global Egg-Based Flu Vaccines market?

3. What is the year over year growth of the global Egg-Based Flu Vaccines market?

4. What is the production and production value of the global Egg-Based Flu Vaccines market?

5. Who are the key producers in the global Egg-Based Flu Vaccines market?